(Q50575830)

English

The role of thyroid autoantibodies in the development of thyroid dysfunction in Taiwanese chronic hepatitis C patients with interferon-alpha and ribavirin combination therapy.

scientific article published in June 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/16842442

The role of thyroid autoantibodies in the development of thyroid dysfunction in Taiwanese chronic hepatitis C patients with interferon-alpha and ribavirin combination therapy. (English)

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/16842442

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

chronic hepatitis C

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/16842442

author name string

Chuang WL

2

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/16842442

Dai CY

3

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/16842442

Chen SC

4

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/16842442

Lin ZY

5

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/16842442

Lee LP

6

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/16842442

Lee PL

7

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/16842442

Wang LY

8

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/16842442

Hsieh MY

9

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/16842442

Chang WY

10

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/16842442

Yu ML

11

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/16842442

publication date

1 June 2006

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/16842442

Journal of Viral Hepatitis

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/16842442

13

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/16842442

6

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/16842442

396-401

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/16842442

A prospective study on treatment of chronic hepatitis C with tailored and extended interferon-alpha regimens according to pretreatment virological factors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00705.X

21 January 2018

Virologic factors related to interferon-alpha-induced thyroid dysfunction in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00705.X

21 January 2018

Prevalence and significance of thyroid autoantibodies in patients with chronic hepatitis C virus infection: a prospective controlled study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00705.X

21 January 2018

Ribavirin polarizes human T cell responses towards a Type 1 cytokine profile.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00705.X

21 January 2018

Thyroid dysfunction during treatment of chronic hepatitis C with interferon alpha: no association with either interferon dosage or efficacy of therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00705.X

21 January 2018

The addition of ribavirin to interferon-alpha therapy in patients with hepatitis C virus-related chronic hepatitis does not modify the thyroid autoantibody pattern but increases the risk of developing hypothyroidism

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00705.X

21 January 2018

Increased risk of autoimmune thyroid disease in hepatitis C vs hepatitis B before, during, and after discontinuing interferon therapy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00705.X

21 January 2018

Thyroid disorders in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00705.X

21 January 2018

Clinical review 169: Interferon-alpha-related thyroid disease: pathophysiological, epidemiological, and clinical aspects

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00705.X

21 January 2018

Incidence of thyroid dysfunction during interferon alfa-2b and ribavirin therapy in men with chronic hepatitis C: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00705.X

21 January 2018

The antiviral compound ribavirin modulates the T helper (Th) 1/Th2 subset balance in hepatitis B and C virus-specific immune responses

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00705.X

21 January 2018

Identifiers

10.1111/J.1365-2893.2005.00705.X

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/16842442

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/16842442

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50575830&oldid=1540637808"